title: Methodology of OTA's report on drug labeling in developing countries.
abstract: This article discusses the methodology of the OTA Project on Drug Labeling in Developing Countries. This report describes (a) the process of the project; (b) observations from a field visit to Thailand; (c) the development of the multinational pharmaceutical industry; and (d) influences on multinational pharmaceutical companies from their home countries, host countries, international organizations, self-regulation, and public interest groups. The results of the assessment will appear in the final report to Congress.
authors.affiliation: OTA Health Program, Washington, DC 20003.
authors.forename: H
authors.initials: H
authors.lastname: Gelband
authors.forename: J
authors.initials: J
authors.lastname: Corrigan
authors.forename: R
authors.initials: R
authors.lastname: McDonough
mesh_terms: D003254:Consumer Advocacy; D003906:Developing Countries; D004345:Drug Industry / Q000331:legislation & jurisprudence; D004348:Drug Labeling / Q000379:methods*; D004335:Drug and Narcotic Control; D013673:Technology Assessment, Biomedical; D013785:Thailand; D014481:United States; D014491:United States Office of Technology Assessment